DAVID J. MAZZO, PHD

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

LISATA THERAPEUTICS, INC.

Filing Date Source Excerpt
2015-06-08 David J. Mazzo was appointed as Caladrius’ Chief Executive Officer and a member of our Board on January 5, 2015. Dr. Mazzo brings to the Company over 30 years of experience in the pharmaceutical industry.
2016-05-10 Dr. Mazzo brings to the Company over 30 years of experience in the pharmaceutical industry.

Data sourced from SEC filings. Last updated: 2025-07-01